Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011115
Filing Date
2025-04-21
Accepted
2025-04-21 17:15:25
Documents
1
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 form4-04212025_050421.html 4  
1 form4-04212025_050421.xml 4 4132
  Complete submission text file 0001415889-25-011115.txt   5808
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TVARDI THERAPEUTICS, INC. 3 SUGAR CREEK CTR BLVD, STE 525 SUGAR LAND TX 77478
Business Address
Conn Avi Daniel (Reporting) CIK: 0002064982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 25854370